Advanced Raman Identification for White Powder, Unknowns, Drugs and Narcotics

The APEX R7 from DetectaChem redefines what field ready identification looks like.

Developed in collaboration with the U.S. Department of Defense, the APEX R7 expands the capability limits for handheld Raman spectrometers to be the top of its class in accurate, user-friendly explosive, HME, chemical, drug and narcotic identification and mixture analysis.

With vast technology advancements over older handheld Raman spectrometer systems, the APEX R7 delivers faster results, more complex mixture analysis, more safety features and more reporting features.

The APEX R7 is the go-to modern solution for law enforcement, first responders and hazardous material technicians seeking the latest in threat identification.

Vast Library of Explosives, Chemicals and Drugs

The APEX R7contains over 24,000 library items including military explosives, homemade explosive materials, toxic industrial chemicals and materials, drugs, explosives precursors, plastics and common household materials.

Interoperable Display Capabilities

Connect the APEX R7 to Apple or Android smartphones and tablets and use with the Mobile Detect App or pair with SEEKER Pro for dual trace detection and identification capabilities.

Add Detection Capability with MopbileDetect

The APEX R7 intuitively prompts use of specific MobileDetect explosive and drug pouches to add critical trace and residue detection to compliment and expand Raman identification results.

Tests include trace nitroaromatics, inorganic nitrates, chlorates, fentanyl, heroin, xylazine, THC, CDB, mushrooms and many more.

FEATURES

• Miniaturized handheld Raman spectrometer.
• Non-contact testing of explosives, chemicals drugs, narcotics, precursors and mixtures
• Fast results, 20 seconds or less.
• Cross-Peak Correlation algorithm for high accuracy library matching results and mixtures.
• Ultra-simple operation with no downtime or calibration.
• Ruggedized for the most extreme situations.
• Robust and customizable report creation.